Working… Menu

A Trial Evaluating Safety of Chronic Therapy With Certolizumab Pegol in Crohn's Disease

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00358683
Recruitment Status : Withdrawn
First Posted : August 1, 2006
Last Update Posted : May 28, 2012
Information provided by:
UCB Pharma

No Study Results Posted on for this Study
Study was withdrawn before participants were enrolled.
Recruitment Status : Withdrawn
Primary Completion Date : No date given
Study Completion Date : No date given